Rafferty Asset Management »

Cidara Therapeutics shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 32k 95.76

More positions owned by Rafferty Asset Management

Ishares Tr 20 Yr Tr Bd Etf (TLT)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Apple (AAPL)
Advanced Micro Devices (AMD)
Ishares Tr China Lg-cap Etf (FXI)
Qualcomm (QCOM)
Micron Technology (MU)
Vaneck Etf Trust Gold Miners Etf (GDX)
Intel Corporation (INTC)
Texas Instruments Incorporated (TXN)
Lam Research Corp Com New (LRCX)

View all positions for Rafferty Asset Management

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Point72 Asset Management
BVF
Vivo Capital
Vanguard Group
BlackRock
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
Morgan Stanley
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics